Serologic Markers Do Not Predict Histologic Severity or Response to Treatment in Patients With Autoimmune Hepatitis
Authors:
- Pradnya MitrooPMPradnya Mitroo
- Alessandro BombonatiABAlessandro Bombonati
- Victor J. NavarroVNVictor J. Navarro
- Simona RossiSRSimona Rossi
- Raphael RubinRRRaphael Rubin
- Steven K. HerrineSHSteven K. Herrine
- 1 January 2009
- journal article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 7 (1) , 98-103
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Autoimmune liver serology: Current diagnostic and clinical challengesWorld Journal of Gastroenterology, 2008
- Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver diseaseHepatology, 2007
- Autoimmune Hepatitis: Effect of Symptoms and Cirrhosis on Natural History and Outcome *Hepatology, 2005
- Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis GroupJournal of Hepatology, 2004
- Diagnosis and treatment of autoimmune hepatitisHepatology, 2002
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?Journal of Hepatology, 1998
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Clinical Features and Prognostic Implications of Severe Corticosteroid-Treated Cryptogenic Chronic Active HepatitisMayo Clinic Proceedings, 1990
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981